Overview
Dr SLN Chandra Mohan had been trained at one of the
most renowned Cancer institutes of India, CMC Hospital, Vellore and the Kidwai
Memorial Institute of Oncology at Bangalore, where some of the highest number
of Parotid tumour cases are operated every year. With extensive experience and
added skill in managing Facial nerve, Dr SLN Chandra Mohan is a master expert
in operating Parotid tumours with added Facial nerve preservation.
Clinical Presentation & Diagnosis
- Symptoms: Most patients present with a slow-growing, painless mass. Persistent pain, rapid growth, or facial weakness are significant "red flags" that often correlate with malignancy or nerve infiltration.
- Diagnostic Standard: Fine Needle Aspiration Cytology (FNAC/FNAB) is the preferred primary diagnostic tool.
- Imaging: Contrast-enhanced MRI
Surgical Management & Facial Nerve Preservation
Surgery is the definitive treatment for parotid tumours. The extent of the procedure is dictated by the tumour's location and grade:
- Superficial Parotidectomy
- Total Conservative Parotidectomy
- Facial Nerve Monitoring (IONM): For advanced, recurrent, or deep-lobe tumours, Intraoperative Facial Nerve Monitoring is a critical tool used to map and protect the nerve branches. This technology provides real-time feedback, significantly reducing the risk of accidental injury during complex dissections.
- Nerve Grafting: If the cancer has
directly invaded the facial nerve, the involved segment is resected, and
immediate micro vascular nerve grafting is performed to restore future
function. This is done under Magnification with aid of Loupes/Microscope
and done meticulously , and with precision , done only in few centers in
India, with our centre being one among them where surgical expertise is required in
the nerve grafting technique.
Neck Management & Adjuvant Therapy
- Neck Dissection: For all cases of Malignant parotid tumours
- Radiotherapy: Postoperative radiation is indicated for advanced stages, high-grade histology, positive margins, or perineural invasion.
Chemotherapy: As per ASCO guidelines, the role of adjuvant chemotherapy remains investigational and is typically reserved for clinical trials or palliative settings.
Post-Operative Expectations
- Temporary Weakness: Literature suggests temporary facial nerve dysfunction occurs in 25–40% of cases due to surgical handling reduced further at our centre with added advantage of Facial nerve monitor .Most patients see a full recovery within 8–12 weeks.
- Permanent Injury: The risk of permanent nerve damage is low (1–2%) but increases with the complexity of recurrent or invasive cancers.
At our centre the risk of Permanent Facial nerve
injury is <2% with further reduction of the palsy with added expertise in
nerve grafting technique.